Shanghai Fosun Pharmaceutical approves repurchase and cancellation of over 1 million restricted shares
Shanghai Fosun Pharmaceutical has approved the repurchase and cancellation of over 1 million restricted shares for approximately 22.8 million yuan. The move will reduce the company's issued share capital to 2,671,326,465 shares and its registered capital by 1.1 million yuan.